Skip to main content
. 2021 Aug 19;11:16839. doi: 10.1038/s41598-021-96107-y

Figure 3.

Figure 3

Increased vitreal intensity after “post-blast” siCASP2 intravitreal injections, but no changes in retinal thickness and ED1+ cells in the ON after b-ITON. (A) Representative OCT scans. (B) There were no difference in GCC thickness between any groups (P = 0.121, ANOVA). (C) Vitreous intensity normalised to RPE intensity increased after b-ITON with siEGFP and siCASP2 intravitreal injections compared to b-ITON with no injections (P = 0.001, GEE) and in eyes receiving siCASP2 injections compared to siEGFP injections (P = 0.002, post-hoc Tukey). (D) There were no differences in total retinal thickness between any groups (P = 0.1012, ANOVA). (E) Representative ON immunofluorescent images stained for DAPI (blue) and ED1 (red). (F) ED1+ cells infiltrate the ON after b-ITON and with “post-blast” injections, although ED1+ cell counts did not reach significance (P = 0.23, ANOVA). Scale bar for (E) = 100 μm. Error bars represent mean ± SEM.